UltraJect

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved August 1996

Specific Treatments:

chronic pain

Find Related Trials for The Following Conditions

General Information

The UltraJect Morphine Sulfate Injection has been approved in two dosage strengths. It is the first terminally sterilized plastic syringe intended for use with patient-controlled pain management. The injection system allows patients to dispense their own medication. Morphine sulfate is used to treat moderate to severe pain such as that associated with post-operative surgical pain or cancer.